Newsletters
- All
- Can you help?
- CARB-X
- CDC
- FDA
- Government Action
- Jobs
- Meetings
- PK & PK-PD
- Push/Pull
- R&D Insight
- RFPs
- Something Different
- Summaries
- Wellcome Trust
- WHO
- Wonkish
- All
- Can you help?
- CARB-X
- CDC
- FDA
- Government Action
- Jobs
- Meetings
- PK & PK-PD
- Push/Pull
- R&D Insight
- RFPs
- Something Different
- Summaries
- Wellcome Trust
- WHO
- Wonkish
G7 Health Ministers: Pull incentives to support stewardship, access, and innovation
Dear All, The G7 Health Ministers met 19-20 May 2022 in Berlin. As you might expect, their communique covered a …
CARB-X renewed x 10 years! Strong calls for PASTEUR!
Dear All, On the heels of yesterday’s (i) patient-focused meeting at the Capitol yesterday where 5 Members of Congress spoke …
3 June 2022 FDA workshop: Developing for uncomplicated UTI (uUTI)
Dear All, It doesn’t rain … it pours! Just seconds after sending out a newsletter on the 18 May et …
Starting 18 May: #SquashSuperbugs, Salt in My Soul (movie), and more!
Dear All, Building on last year’s call from PFID to declare 18 May the annual “Squash Superbugs Day of Action,” we …
Meetings and more: Pandemic wargames! NIAID developer workshop! New stewardship prize!
Dear All, As suggested by the subject line, this newsletter is a bit of a mish-mash of time-critical news about …
Job Opportunity In Berlin With Global AMR R&D Hub!
Dear All, The Global AMR R&D Hub is looking for Head of the Global AMR R&D Hub Secretariat! The position would be …
Antibiotic supply chains: Challenges & Opportunities
Dear All, In a report entitled Understanding the Antibiotic Manufacturing Ecosystem: A view of global supply chains, pressure points, and implications …
NIAID BAA To Support In Vitro Diagnostic Product Development
Dear All, Excitingly, NIAID has released a new BAA (Broad Agency Announcement) entitled “Diagnostics Pre-Clinical Services Program.” Similar to the prior …
UK Pull (Netflix) pilot: QALY value of new antibiotics implies societal value > 10m GBP/year!
Dear All (and with thanks to Kevin Outterson for co-authoring this newsletter), We’ve written before about the UK’s “Netflix” pilot antibiotic …
ICARS seeks Executive Director
Dear All, An interesting job listing for you today! The International Centre for Antimicrobial Resistance Solutions (ICARS) is looking for an …
Future Leaders Against AMR – Fireside Chat with Founder!
Dear All, As some of you may have seen on Twitter, the Future Leaders Against AMR have been busy! I …
Pull mechanisms: Private capital can multiply Subscription (Netflix) and TEV models!
Dear All: Three recent papers bring together an instructive perspective on Pull incentives for the #FireExtinguishersOfMedicine. The first two papers …
Comment on US 2023-2026 National Health Security Strategy
Dear All, The US Office of the Assistant Secretary for Preparedness & Response (ASPR) is looking for comments on the 2023-2026 National Health …
Implementation Handbook on National Action Plans from WHO
Dear All, Continuing on the theme of helping countries develop their own national action plans, WHO released the “WHO implementation …
Discussing Details of ATMF’s 2021 AMR Benchmark Report!
Dear All, As you may remember, last fall I wrote a newsletter about ATMF’s 3rd update to the AMR Benchmark …
New pipeline analysis: Cancer projects were funded 17x more than antibacterials during 2011-2020
Dear All (wonkish alert: coffee up, settle in, and read the reports!), As you will recall, WHO’s most current pipeline …
Sign a letter in support of antifungal R&D … in support of PASTEUR!
Dear All: As you know if you are a regular reader of this newsletter, I think that creation of suitable Pull …
RFP: Gender inequality in AMR (with a focus on sub-Saharan Africa)
Dear All, Continuing with the theme of socio-economic inequality and AMR that we discussed in prior newsletters (31 Jan 2022, …
CC4CARB: (free!) rationally designed compound libraries based on your ideas!
Dear All, NIAID and RTI International have recently announced the initiation of CC4CARB Chemistry Center for Combating Antibiotic Resistance). In …
RFP: Climate-Sensitive Infectious Disease Modelling
Dear All, And now for something really different! With the recent GRAM report (20 Jan 2022 newsletter) showing that AMR is …
